Identification of Cardiac MRI Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
Aims Pulmonary arterial hypertension is a life-shortening condition. The European Cardiac and Respiratory Societies (ESC/ERS) and REVEAL 2.0 risk score calculator identify thresholds to predict 1-year mortality. This study evaluates whether cardiac-MRI thresholds can be identified and used to aid risk stratification and facilitate decision making. Methods Consecutive patients with pulmonary arterial hypertension (n=438) undergoing cardiac-MRI were identified from the ASPIRE-MRI database. Thresholds were identified from a discovery cohort and evaluated in a test cohort. Results A right ventricular-end-systolic-volume-index-%predicted threshold of 227% or a left ventricular-end-diastolic-volume-index of 58ml/m2 identified patients at low (<5%) and high (>10%) risk of 1-year mortality. These metrics identified 63% and 34% of patients as low risk, respectively. A right ventricular ejection fraction >54%, 37-54% and <37% identified 21%, 43% and 36% of patients at low, intermediate and high-risk of 1-year mortality, respectively. At follow-up cardiac-MRI patients who improved to, or were maintained in a low risk group had a one-year mortality <5%. Right ventricular-end-systolic-volume-index-%predicted independently predicted outcome and when used in conjunction with the REVEAL 2.0 risk score calculator or a modified French Pulmonary Hypertension registry approach improved risk stratification for one-year mortality. Conclusion Cardiac-MRI can be used to risk stratify patients with pulmonary arterial hypertension using a threshold approach. Right ventricular-end-systolic-volume-index-%predicted can identify a high percentage of patients at low-risk of one-year mortality and when used in conjunction with current risk stratification approaches it can improve risk stratification. This study supports further evaluation of cardiac-MRI in risk stratification in PAH. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).